Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125276371 | 12527637 | 1 | I | 20160620 | 20160705 | 20160705 | EXP | RS-HERITAGE PHARMACEUTICALS-2016HTG00171 | HERITAGE | JOVIC-STOSIC J, PUTIC V, VUKCEVIC N, ET AL. ANTIDOTAL USE OF INTRAVENOUS LIPID EMULSION: 5 YEARS^ EXPERIENCE IN AN INTENSIVE CARE UNIT. CLIN TOXICOL. 2016;54(4):476 | 0.00 | Y | 0.00000 | 20160705 | OT | RS | RS |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125276371 | 12527637 | 1 | PS | VERAPAMIL HYDROCHLORIDE. | VERAPAMIL HYDROCHLORIDE | 1 | Unknown | U | 71880 | ||||||||||
125276371 | 12527637 | 2 | SS | UNSPECIFIED BENZODIAZEPINES | BENZODIAZEPINE | 1 | Unknown | U | 0 | ||||||||||
125276371 | 12527637 | 3 | SS | ENALAPRIL | ENALAPRIL | 1 | Unknown | U | 0 | ||||||||||
125276371 | 12527637 | 4 | SS | CILAZAPRIL | CILAZAPRIL ANHYDROUS | 1 | Unknown | U | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125276371 | 12527637 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125276371 | 12527637 | Arrhythmia | |
125276371 | 12527637 | Circulatory collapse | |
125276371 | 12527637 | Hypotension | |
125276371 | 12527637 | Poisoning |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |